Table 1. Assessment of sentences that describe the level of significance and describe the statistical hypothesis test results of 11 original articles published in the Journal of Lipid and Atherosclerosis in 2022.
| No. | Last name of first author | Year | Volume | Issue | Sentences that describe the level of significance | The value of significance level set by the researcher | Examples of sentences describing statistical hypothesis test results | Suggested sentences |
|---|---|---|---|---|---|---|---|---|
| 1 | Kim et al.1 | 2022 | 11 | 1 | p-value less than 0.05 was considered statistically significant. | 0.05 | There were no significant differences in statin use, HDL-cholesterol, or LDL-cholesterol between patients with and without an extreme risk for ASCVD. | There was no statistically significant difference in statin use, HDL-cholesterol, or LDL-cholesterol between patients at extreme risk for ASCVD and those without. |
| 2 | Jeon et al.3 | 2022 | 11 | 1 | Statistical significance was considered when p<0.05. | 0.05 | There was no significant difference in all-cause mortality among the 13 studies comparing SUs and DPP4 inhibitors as add-on therapies to metformin (random-effect relative risk [RR], 1.14; 95% confidence interval [CI], 0.98–1.33; I2=0%; p=0.098) | There was no statistically significant difference in all-cause mortality among the 13 studies comparing SUs and DPP4 inhibitors as add-on therapies to metformin (random-effect relative risk [RR], 1.14; 95% confidence interval [CI], 0.98–1.33; I2=0%; p=0.098) |
| 3 | Lee et al.4 | 2022 | 11 | 2 | The volcano plots were described through the “EnhancedVolcano” package with a significant cutoff, lower p-value than 0.01. | 0.01 | These eight genes showed significant associations with AD pathology. | These 8 genes were statistically associated with AD pathology. |
| 4 | Cho et al.5 | 2022 | 11 | 2 | A 2-sided p-value of less than 0.05 was considered statistically significant. | 0.05 | There were significant differences in mortality rates across the 4 groups. | There were statistically significant difference in mortality between the 4 groups. |
| 5 | Ochin et al.6 | 2022 | 11 | 2 | p-values <0.05 were considered to be statistically significant. | 0.05 | This distribution was statistically significant (p<0.001) for palmitic acid, LA, oleic acid and stearic acid across all groups. | No suggestion. |
| 6 | Lan et al.7 | 2022 | 11 | 2 | A 2-sided p-value of <0.05 was used to define statistical significance. | 0.05 | The proportion of patients attaining lipid targets according to year of CABG surgery was not significantly different, as presented in Supplementary Table 1. | The proportion of patients attaining lipid targets according to year of CABG surgery was not statistically significantly different, as presented in Supplementary Table 1. |
| 7 | Cho et al.2 | 2022 | 11 | 2 | Not presented. | None. | The risks of MI (p for interaction <0.001) and death (p for interaction=0.0006) for the 4th quartile of the TyG index in women were significantly higher than those of men. | The risks of MI (p for interaction <0.001) and death (p for interaction=0.0006) for the 4th quartile of the TyG index in women were statistically significantly higher than those of men at the 5% significance level. |
| 8 | Tarkhnishvili et al.8 | 2022 | 11 | 2 | Significant difference was accepted when p<0.05. | 0.05 | Mean values of palmitate oxidation were increased by 2.7-fold in vehicle-treated db/db mice compared to vehicle-treated C57BLKS/J mice; statistical significance was however not achieved (Fig. 2E). | No suggestion. |
| 9 | Jeong et al.9 | 2022 | 11 | 3 | p<0.05 was considered statistically significant. | 0.05 | Among participants not taking statins, LDL-C levels ≥120 mg/dL were significantly associated with MI risk (1.33 [1.27–1.40]). LDL-C ≥120 mg/dL was significantly associated with increased MI risk in statin users compared with statin users with LDL-C <80 mg/dL. | Among participants not taking statins, an LDL-C level ≥120 mg/dL was statistically significantly associated with MI risk (1.33 [1.27–1.40]). LDL-C ≥120 mg/dL was statistically significantly associated with an increased risk of MI in statin users compared to statin users with LDL-C <80 mg/dL. |
| 10 | Hayıroğlu et al.10 | 2022 | 11 | 3 | As the level of statistical significance, a p-value of ≤0.05 was chosen. | 0.05 | In regard to laboratory measurements, the patients with long-term MACEs had significantly higher levels of FBG, creatinine, TG, the TyG index. | In regard laboratory measurements, the patients with long-term MACEs had statistically significantly higher levels of FBG, creatinine, TG, and TyG indices |
| 11 | Nam et al.11 | 2022 | 11 | 3 | All variables with a p<0.05 were considered statistically significant. | 0.05 | CMBs did not have statistical significance with AIP. | No suggestion. |
HDL, high-density lipoprotein; LDL, low-density lipoprotein; ASCVD, atherosclerotic cardiovascular disease; SU, sulfonylurea; DPP4, dipeptidyl peptidase-4; AD, Alzheimer's disease; LA, left atrial; CABG, coronary artery bypass graft; MI, myocardial infarction; TyG index, triglyceride-glucose; LDL-C, low-density lipoprotein cholesterol; MACE, major adverse cardiovascular event; FBG, fasting blood glucose; TG, triglyceride; CMB, cerebral microbleed; AIP, atherogenic index of plasma.